NDC 50090-6442-05 - Phenazopyridine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6442
- Requested NDC
- 50090-6442-05
- Package NDCs from labels
- 50090-6442-0, 50090-6442-5, 50090-6442-8, 50090-6442-05
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2023-04-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Phenazopyridine Hydrochloride - A-S Medication Solutions | A-S Medication Solutions | 2023-04-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6442-0 | Phenazopyridine Hydrochloride | 10 in 1 BOTTLE | TABLET | 10 | 4 | |
| 50090-6442-5 | Phenazopyridine Hydrochloride | 12 in 1 BOTTLE | TABLET | 12 | 4 | |
| 50090-6442-8 | Phenazopyridine Hydrochloride | 6 in 1 BOTTLE | TABLET | 6 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6442 | PHENAZOPYRIDINE HYDROCHLORIDE (PHENAZOPYRIDINE) TABLET [A-S MEDICATION SOLUTIONS] | 4 | Current NDC, 3 package rows | 20230427_7aae87e6-92be-4e66-aca1-5be7f24a8c2d.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6442-0 | EA - Each | 50090-6442 | 04652ff3-e84f-4999-afa2-8f9907c4f952 | 1 | 2023-06-06 |
| 50090-6442-5 | EA - Each | 50090-6442 | a785f392-7b56-4829-916d-ee618cd201a6 | 1 | 2023-06-06 |
| 50090-6442-8 | EA - Each | 50090-6442 | b5602b6f-7e7b-4168-8230-d4282e6be259 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cystex Max UTI Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Clarion Brands, LLC | a4d34c20-62af-4a3c-ad2c-046ba08d1ef6 | 2026-11-09 | Warnings | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | PD-Rx Pharmaceuticals, Inc. | 1522921b-d6c2-420d-ba0d-39ac16ba8b37 | 2026-10-30 | Adverse reactions | 1094107 0EWG668W17 |
| Cystex Max Strength UTI Pain Relief | CYSTEX MAX STRENGTH UTI PAIN RELIEF | Clarion Brands LLC | 57482f71-80d3-b20d-e063-6394a90a0cf4 | 2026-10-28 | Warnings | 0EWG668W17 |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | FZ989GH94E |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-10-14 | Warnings | 3NXW29V3WO |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 5dd1e5aa-df98-8482-e063-6294a90a878d | 2026-10-14 | Warnings, Adverse reactions | 1094104 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | PD-Rx Pharmaceuticals, Inc. | c1591037-62f4-469f-8bb2-a82e49dfbecf | 2026-10-12 | Adverse reactions | 1094104 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | Preferred Pharmaceuticals Inc. | 132cc592-6b03-4b75-bf39-df476fb9dc81 | 2026-10-09 | Adverse reactions | 1094107 0EWG668W17 |
| Foster and Thrive Neighbor Pharmacy Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Redpharm Drug | 5d629ecc-c737-05f6-e063-6294a90a4390 | 2026-10-09 | Warnings | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ce702be2-eec2-4346-965e-f1f6ba342fc9 | 2026-10-09 | Warnings, Adverse reactions | 1094107 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc | 96308f8c-66e7-486a-a5c0-ee9a133ad051 | 2026-10-09 | Warnings, Adverse reactions | 1094104 0EWG668W17 |
| Foster and Thrive Maximum Strength Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Sportpharm LLC | 42abac37-557f-4372-b55a-12ddae71ec8b | 2026-10-06 | Warnings | 0EWG668W17 |
| REFRESH Classic | POLYVINYL ALCOHOL, POVIDONE | Allergan, Inc. | 31bf1d6c-9719-4060-b6a3-409a2fe7b560 | 2026-09-15 | Warnings | FZ989GH94E |
| Leader Artificial Tears 15 mL | POLYVINYL ALCOHOL, POVIDONE | Cardinal Health | 8cccc589-3a8e-baad-e053-2a95a90ab8c7 | 2026-09-09 | Warnings | FZ989GH94E |
| FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPS | POVIDONE, POLYVINYL ALCOHOL SOLUTION | Harrow Eye, LLC | 049e9cc9-0663-53bc-e063-6294a90a2c4f | 2026-09-04 | Warnings | FZ989GH94E |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | REMEDYREPACK INC. | 49baf6e5-133a-4e1a-9740-506673d27caf | 2026-08-21 | Warnings, Adverse reactions | 1094107 0EWG668W17 |
| Rohto Optic Glow | NAPHAZOLINE HYDROCHLORIDE, POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | df9c5f7c-96e6-4b2b-b8cb-21a6a3342dff | 2026-08-20 | Warnings | FZ989GH94E |
| Rohto All-In-One | HYPROMELLOSE, TETRAHYDROZOLINE HYDROCHLORIDE, ZINC SULFATE | The Mentholatum Company | 43e690e4-b381-46e3-838c-33aef5bdadde | 2026-08-20 | Warnings | 3NXW29V3WO |
| Rohto Preservative Free Dry Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | f4b1974c-2412-45f6-b79d-88b8a0bcb608 | 2026-08-18 | Warnings | FZ989GH94E |
| Rohto Dry-Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | 8ea5c6c9-48f4-406a-a2cb-9280c546d87d | 2026-08-18 | Warnings | FZ989GH94E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.